Marko Jukič

发表

Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.

J. Kos, N. Coquelle, J. Colletier, 2018, European journal of medicinal chemistry.